Gedeon Richter Competitors and Similar CompaniesClear all

Gedeon Richter's competitors and similar companies include AMAG Pharmaceuticals, TherapeuticsMD, Besins Healthcare and Theramex.

	Gedeon Richter Gedeon Richter is a pharmaceutical manufacturing, research, and development company.	AMAG Pharmaceuticals AMAG Pharmaceuticals is a pharmaceutical company that develops and delivers medicines across a range of therapeutic areas.	TherapeuticsMD TherapeuticsMD is a pharmaceutical company focused on producing generic prescriptions and over-the-counter products for women.	Besins Healthcare Besins Healthcare is a company that specializes in therapies for gynecology and andrology.	Theramex Theramex is a pharmaceutical company that develops treatments for women's health.
Founding Date	Founding Date 1901	Founding Date 1981	Founding Date 2008	Founding Date 1885	Founding Date 2018
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech clinical research drug development pharma women's health	Tags Healthcare clinical research drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health
Locations	Locations Budapest, HU HQ Yerevan, AM Sydney, AU Wien, AT Baku, AZ Minsk, BY Dilbeek, BE see more	Locations Waltham, US HQ	Locations Boca Raton, US HQ	Locations Monaco, MC HQ Chatswood, AU Bruxelles, BE Sao Paulo, BR see more	Locations London, GB HQ Sydney, AU Vilvoorde, BE Paris, FR Berlin, DE Milan, IT Warsaw, PL see more
Employees	Employees 10,943	Employees 3751% decrease	Employees 34844% increase	Employees 1,1641% increase	Employees 481
Valuation ($)	Valuation ($) 5.5 b	Valuation ($) N/A	Valuation ($) 18.1 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) Ft929b (FY, 2025)	Revenue (est.) $327.8m (FY, 2019)	Revenue (est.) $3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods Ft238b (FY, 2025)	Cost of goods $107.2m (FY, 2019)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit Ft708b (FY, 2025)	Gross profit ($106.9m) (FY, 2019)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income Ft232.2b (FY, 2025)	Net income ($466.5m) (FY, 2019)	Net income ($569k) (FY, 2025)	Net income N/A	Net income N/A